EX-FILING FEES 27 ea021076803ex-fee_acuren.htm FILING FEE TABLE

Exhibit 107

 

Calculation of Filing Fee Tables

 

Form S-4
(Form Type)

 

Acuren Corporation
(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities 

 

   Security
Type
  Security Class Title  Fee
Calculation
Or Carry
Forward Rule
  Amount
Registered(1)(2)
    Proposed
Maximum
Offering
Price Per
Unit
    Maximum
Aggregate
Offering Price
    Fee Rate    Amount of
Registration
Fee
  
   Newly Registered Securities 
Fees to be Paid  Equity  Common Stock, par value $0.0001 per share  457(f)(2)   131,686,215(3)    $10.249(4)   $1,349,652,017.54    $0.00015310    $206,631.72  
Fees to be Paid  Equity  Warrants to purchase Common Stock  457(f)(1)   18,246,876     (5)    (5)    (5)    (5) 
Fees to be Paid  Equity  Common Stock underlying Warrants  457(g),(i)   4,566,219    $11.58(6)   $52,876,816.02    $0.00015310    $8,095.44  
Fees to be Paid  Equity  Series A Preferred Stock  457 (i)   1,000,000     (5)    (5)    (5)    (5) 
Carry Forward Securities
Carry Forward Securities                               
Total Offering Amounts                    $214,727.16  
Total Fees Previously Paid                       
Total Fee Offsets                       
Net Fee Due                    $214,727.16  

 

(1)Shortly after the effectiveness of this registration statement, Acuren Corporation (formerly known as Admiral Acquisition Limited) (the “Registrant”) intends to effect a discontinuance under Section 184 of the BVI Business Companies Act, 2004 (as amended) and a domestication under Section 388 of the General Corporation Law of the State of Delaware, pursuant to which the Registrant’s jurisdiction of incorporation will be changed from the British Virgin Islands to the State of Delaware, United States of America. All securities being registered will be issued by the Registrant after such domestication, as the continuing entity following the domestication.

(2)Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers an indeterminate number of additional shares of Common Stock which may be offered and issued by reason of any stock dividend, stock split, recapitalization or other similar transaction.

(3)The shares to be registered include (1) up to 128,976,215 shares of common stock issuable upon the domestication in exchange for the Registrant’s outstanding ordinary shares, (2) 1,000,000 shares of common stock issuable upon conversion of the Registrant’s outstanding Series A Preferred Stock subsequent to the domestication, and (3) 1,710,000 shares of common stock issuable upon exercise or settlement of the Registrant’s options and restricted stock units subsequent to the domestication.

(4)Pursuant to Rule 457(f)(2) under the Securities Act and solely for the purpose of calculating the registration fee, the proposed maximum aggregate offering price per share is based on the aggregate book value of the securities of the Registrant as of June 30, 2024 ($564,722,000) and the shares outstanding and reserved for issuance as of June 30, 2024 (55,100,000).

(5)Pursuant to Rule 457(g), Rule 457(i) and the response to Question 240.06 of the Securities Act Rules Compliance and Disclosure Interpretations, no separate registration fee is required for the warrants and Series A Preferred Stock. The registration fee with respect to the warrants and Series A Preferred Stock has been allocated to the underlying shares of common stock issuable upon exercise of such warrants and conversion of such Series A Preferred Stock and the registration fee for such shares of common stock is calculated in footnote (4) and (6).

(6)Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(g) and 457(i) of the Securities Act and represents the sum of (i) the average ($0.08) of the high ($0.08) and low ($0.08) prices of the warrants on the London Stock Exchange (“LSE”) on July 30, 2024, which is the date such warrants were suspended from trading on the LSE and (ii) the exercise price of $11.50 per ordinary share issuable upon exercise of such warrant.